Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs
by CNBC
CNBC— Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance following better-than-expected first-quarter results.
Silicon Republic—Deciphex partners with Novartis for AI drug research. The collaboration will see the creation and utilisation of an AI suite, to be deployed in pre-clinical pathology assessments. : Deciphex partners with Novartis for AI drug research
WCCB Charlotte—Gastonia Drug Issues On The Rise; How Are First Responders Handling It?. We hear from Police, Medic, and Fire in Gaston County regarding the growing drug trafficking in the area, but decreasing the amount of overdoses.
Investopedia—GM Stock Rises on Earnings Beat, Guidance Boost. General Motors exceeded first-quarter profit and revenue estimates as its net income from North American operations jumped.